Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00402285 · ClinicalTrials.gov registry record · NA
Lycopene or Omega-3 Fatty Acid Nutritional Supplements in Treating Patients With Stage I or Stage II Prostate Cancer
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 84
- Enrollment target
NCT00402285 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 84 participants.
The verdict
NCT00402285, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 84 participants
- Enrollment target
Study Summary
RATIONALE: The use of lycopene, a substance found in tomatoes, or omega-3 fatty acid nutritional supplements may keep cancer from growing in patients with prostate cancer. PURPOSE: This randomized clinical trial is studying lycopene to see how well it works compared to omega-3 fatty acids or a placebo in treating patients with stage I or stage II prostate cancer.
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT lycopene supplement
- DIETARY_SUPPLEMENT fish oil supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2003-04 |
| Est. Completion | 2008-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00402285
The ClinicalTrials.gov registry entry for NCT00402285 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00402285 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00402285 about?
NCT00402285 is a clinical study titled "Lycopene or Omega-3 Fatty Acid Nutritional Supplements in Treating Patients With Stage I or Stage II Prostate Cancer". RATIONALE: The use of lycopene, a substance found in tomatoes, or omega-3 fatty acid nutritional supplements may keep cancer from growing in patients with prostate cancer. PURPOSE: This randomized clinical trial is studying lycopene to see how well it works compared to omega-3 fatty acids or a plac...
What is the current status of trial NCT00402285?
This trial is currently completed. It is a NA study. The enrollment target is 84 participants. The study started on 2003-04. Estimated completion is 2008-01.
What interventions are being tested in trial NCT00402285?
The interventions under investigation include: Placebo (OTHER), lycopene supplement (DIETARY_SUPPLEMENT), fish oil supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00402285?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.